Cost-effectiveness for risk factor determination and management of cardiac magnetic resonance vs. predictive tlr2/tlr4 genetic tests for early anthracycline-induced cardiotoxicity

25 May 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Quick Fire abstract session 5 Cardiac Magnetic Resonance EACVI Premium Access EuroCMR 2017

ESC 365 is supported by

ESC 365 is supported by